“ ANTIBIOTIC DRUGS APPROVED BEFORE NOVEMBER 21, 1997— `` (A) IN GENERAL— Notwithstanding any provision of the Food and Drug Administration Modernization Act of 1997 or any other provision of law, a sponsor of a drug that is the subject of an application described in subparagraph (B) (i) shall be eligible for, with respect to the drug, the 3-year exclusivity period referred to under clauses (iii) and (iv) of subsection (c) (3) (E) and under clauses (iii) and (iv) of subsection (j) (5) (F) , subject to the requirements of such clauses, as applicable. ”

“ With respect to any patent information referred to in paragraph (1) of this subsection that is filed with the Secretary within the 60-day period after the date of the enactment of this Act, the Secretary shall publish such information in the electronic version of the list referred to at section 505 (j) (7) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355 (j) (7) ) as soon as it is received, but in no event later than the date that is 90 days after the enactment of this Act. ”

“ Sec. 3. Mandatory Use of State Public Assistance Reporting Information System (PARIS) Project. (a) In General— Section 1903 (r) of the Social Security Act (42 U.S.C. 1396b (r) ) is amended— (1) in paragraph (1) , in the matter preceding subparagraph (A) , by inserting ``, in addition to meeting the requirements of paragraph (3) , ́ ́ after ``a State must ́ ́; and (2) by adding at the end the following new paragraph ”